Cellosaurus COR-L23/R (CVCL_2008)

Cell line name COR-L23/R
Accession CVCL_2008
Resource Identification Initiative To cite this cell line use: COR-L23/R (RRID:CVCL_2008)
Comments Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
Disease Large cell lung carcinoma (NCIt: C4450)
Derived from metastatic site: Pleural effusion.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_1139 (COR-L23)
Children:
CVCL_2009 (COR-L23/R23-)
Sex of cell Male
Age at sampling 62Y
Category Cancer cell line
Publications

PubMed=3011054; DOI=10.1038/bjc.1986.83
Twentyman P.R., Fox N.E., Wright K.A., Bleehen N.M.
Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cells.
Br. J. Cancer 53:529-537(1986)

PubMed=7903701; DOI=10.1093/jnci/86.2.110
Barrand M.A., Heppell-Parton A.C., Wright K.A., Rabbitts P.H., Twentyman P.R.
A 190-kilodalton protein overexpressed in non-P-glycoprotein-containing multidrug-resistant cells and its relationship to the MRP gene.
J. Natl. Cancer Inst. 86:110-117(1994)

Cross-references
Cell line collections ECACC; 96042339
Cell line databases/resources CLDB; cl5055
Ontologies CLO; CLO_0002587